Abstract Background: The use of psychedelics is currently increasing in the United States. Awareness of clinical trials investigating the therapeutic…
Abstract Introduction: The Department of Health and Human Services recently recommended rescheduling cannabis from Schedule I to Schedule III, which…
Abstract Objective: There are numerous reports of people substituting medical cannabis (MC) for medications. Our obejctive was to investigate the…
Abstract This survey study characterizes past-year use prevalence and factors associated with use of cannabidiol, cannabigerol, cannabinol, and Δ8-tetrahydrocannabinol among…
Abstract Objective: Understanding how medical cannabis (MC) use is integrated into medical practice for rheumatic disease management is essential. We…
Abstract Novel cannabinoids require systematic research to inform policies and practices. There is a growing interest in semi-synthetic cannabinoids by…
Abstract Background: Patients use medical cannabis for a wide array of illnesses and symptoms, and many substitute cannabis for pharmaceuticals.…
Abstract Background: Products containing delta-8-THC became widely available in most of the USA following the 2018 Farm Bill and by…
Abstract Background: People report using cannabis as a substitute for prescription medications but may be doing so without the knowledge…
Abstract Background: The ongoing COVID-19 pandemic strains the medical system, limiting access to healthcare services. Many people use cannabis medically…